iLoF (private company)
See something wrong or missing? Let us know
Offices:Oxford, Porto
Business model:B2B
iLoF is enabling a new era of personalized, precision medicine, by providing screening and stratification tools in an affordable, fast, portable way. Currently focusing a patented platform technology on the epidemic of our century: Alzheimer's disease.
Investors:
we tracked 10 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 5.1M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to iLoF
Name | Criteria | |
---|---|---|
![]() |
Clustermarket
80%
|
|
![]() |
Exogene
80%
|
|
![]() |
Novai
77%
|
|
![]() |
Atai Life Sciences
75%
|
|
![]() |
Sano Genetics
75%
|
|
![]() |
Causaly
75%
|
|
![]() |
Overwatch Research
75%
|
|
![]() |
bit.bio
75%
|
|
![]() |
Synthace
75%
|
|
![]() |
Monocl
73%
|
|